Nutex Health (NUTX) Depreciation & Amortization (IS) (2014 - 2026)

Nutex Health's Depreciation & Amortization (IS) history runs 7 years deep, the most recent figure standing at $5.5 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (IS) rose 7.86% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $20.9 million (up 5.29% YoY), while the FY2025 annual figure was $20.5 million, up 8.21% from the prior year.
• Depreciation & Amortization (IS) came in at $5.5 million for Q1 2026 at Nutex Health, up from $5.2 million in the prior quarter.
• In the past five years, Depreciation & Amortization (IS) ranged from a high of $5.5 million in Q1 2026 to a low of $2.4 million in Q1 2022.
• A 5-year average of $4.5 million and a median of $4.7 million in 2023 frame the typical range for Depreciation & Amortization (IS).
• Across the five-year window, Depreciation & Amortization (IS) soared 131.34% in 2022 and slipped 1.78% in 2025, its largest moves.
• Nutex Health's Depreciation & Amortization (IS) stood at $3.3 million in 2022, then jumped by 43.13% to $4.7 million in 2023, then grew by 12.77% to $5.3 million in 2024, then retreated by 1.78% to $5.2 million in 2025, then grew by 5.88% to $5.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (IS) over the past three periods registered $5.5 million, $5.2 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison